nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—ABCC3—Vincristine—muscle cancer	0.0664	0.0724	CbGbCtD
Phenobarbital—ABCC1—Dactinomycin—muscle cancer	0.0662	0.0722	CbGbCtD
Phenobarbital—ABCC3—Etoposide—muscle cancer	0.0608	0.0664	CbGbCtD
Phenobarbital—ABCB11—Vincristine—muscle cancer	0.0574	0.0626	CbGbCtD
Phenobarbital—CYP1A1—Dacarbazine—muscle cancer	0.0472	0.0514	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—muscle cancer	0.0415	0.0453	CbGbCtD
Phenobarbital—ABCC1—Vincristine—muscle cancer	0.0408	0.0445	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—muscle cancer	0.0402	0.0438	CbGbCtD
Phenobarbital—ABCC1—Etoposide—muscle cancer	0.0374	0.0407	CbGbCtD
Phenobarbital—CYP2E1—Dacarbazine—muscle cancer	0.0364	0.0397	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—muscle cancer	0.0359	0.0391	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—muscle cancer	0.0359	0.0391	CbGbCtD
Phenobarbital—ABCC2—Vincristine—muscle cancer	0.0302	0.0329	CbGbCtD
Phenobarbital—ABCC2—Etoposide—muscle cancer	0.0276	0.0302	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—muscle cancer	0.0255	0.0278	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—muscle cancer	0.0247	0.0269	CbGbCtD
Phenobarbital—CYP1A2—Dacarbazine—muscle cancer	0.0211	0.023	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0201	0.022	CbGbCtD
Phenobarbital—CYP3A7—Vincristine—muscle cancer	0.0201	0.022	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—muscle cancer	0.0189	0.0206	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—muscle cancer	0.0183	0.0199	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—muscle cancer	0.0178	0.0194	CbGbCtD
Phenobarbital—ABCB1—Dactinomycin—muscle cancer	0.016	0.0174	CbGbCtD
Phenobarbital—CYP3A5—Vincristine—muscle cancer	0.0151	0.0165	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—muscle cancer	0.0138	0.0151	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—muscle cancer	0.0133	0.0145	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—muscle cancer	0.012	0.0131	CbGbCtD
Phenobarbital—CYP1A2—Etoposide—muscle cancer	0.0103	0.0112	CbGbCtD
Phenobarbital—ABCB1—Vincristine—muscle cancer	0.00984	0.0107	CbGbCtD
Phenobarbital—ABCB1—Etoposide—muscle cancer	0.00901	0.00983	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—muscle cancer	0.00615	0.00671	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—muscle cancer	0.00596	0.0065	CbGbCtD
Phenobarbital—CYP3A4—Vincristine—muscle cancer	0.00589	0.00643	CbGbCtD
Phenobarbital—CYP3A4—Etoposide—muscle cancer	0.0054	0.00589	CbGbCtD
Phenobarbital—CYP3A4—Doxorubicin—muscle cancer	0.00368	0.00402	CbGbCtD
Phenobarbital—Anaemia megaloblastic—Methotrexate—muscle cancer	0.00173	0.036	CcSEcCtD
Phenobarbital—CYP4A11—renal system—muscle cancer	0.00167	0.0473	CbGeAlD
Phenobarbital—CYP4B1—cardiac atrium—muscle cancer	0.00133	0.0378	CbGeAlD
Phenobarbital—GRIA2—embryo—muscle cancer	0.00131	0.0372	CbGeAlD
Phenobarbital—CYP4A11—vagina—muscle cancer	0.00121	0.0343	CbGeAlD
Phenobarbital—Necrosis—Dactinomycin—muscle cancer	0.0012	0.0249	CcSEcCtD
Phenobarbital—Nystagmus—Vincristine—muscle cancer	0.00117	0.0245	CcSEcCtD
Phenobarbital—CYP4B1—tendon—muscle cancer	0.00116	0.0329	CbGeAlD
Phenobarbital—CYP4B1—vagina—muscle cancer	0.00108	0.0306	CbGeAlD
Phenobarbital—Extravasation—Dactinomycin—muscle cancer	0.00108	0.0224	CcSEcCtD
Phenobarbital—Hypocalcaemia—Dactinomycin—muscle cancer	0.00103	0.0214	CcSEcCtD
Phenobarbital—CYP4B1—head—muscle cancer	0.000996	0.0282	CbGeAlD
Phenobarbital—CYP4B1—testis—muscle cancer	0.000962	0.0273	CbGeAlD
Phenobarbital—Extravasation—Vincristine—muscle cancer	0.000961	0.0201	CcSEcCtD
Phenobarbital—Laryngospasm—Etoposide—muscle cancer	0.00091	0.019	CcSEcCtD
Phenobarbital—SLCO2A1—renal system—muscle cancer	0.000891	0.0253	CbGeAlD
Phenobarbital—Necrosis—Etoposide—muscle cancer	0.000866	0.0181	CcSEcCtD
Phenobarbital—Respiratory failure—Vincristine—muscle cancer	0.000854	0.0178	CcSEcCtD
Phenobarbital—Apnoea—Etoposide—muscle cancer	0.000801	0.0167	CcSEcCtD
Phenobarbital—CYP2C18—vagina—muscle cancer	0.0008	0.0227	CbGeAlD
Phenobarbital—SLCO2A1—cardiac atrium—muscle cancer	0.000798	0.0226	CbGeAlD
Phenobarbital—Extravasation—Etoposide—muscle cancer	0.000779	0.0162	CcSEcCtD
Phenobarbital—Coma—Vincristine—muscle cancer	0.000766	0.016	CcSEcCtD
Phenobarbital—CHRNA7—renal system—muscle cancer	0.000731	0.0207	CbGeAlD
Phenobarbital—SLCO2A1—tendon—muscle cancer	0.000695	0.0197	CbGeAlD
Phenobarbital—Lethargy—Dactinomycin—muscle cancer	0.000695	0.0145	CcSEcCtD
Phenobarbital—ABCB11—testis—muscle cancer	0.000695	0.0197	CbGeAlD
Phenobarbital—ABCC3—renal system—muscle cancer	0.000684	0.0194	CbGeAlD
Phenobarbital—GRIA2—head—muscle cancer	0.000665	0.0188	CbGeAlD
Phenobarbital—SLCO2A1—vagina—muscle cancer	0.000645	0.0183	CbGeAlD
Phenobarbital—GRIA2—testis—muscle cancer	0.000642	0.0182	CbGeAlD
Phenobarbital—Hypoxia—Methotrexate—muscle cancer	0.000641	0.0134	CcSEcCtD
Phenobarbital—Body temperature decreased—Doxorubicin—muscle cancer	0.000629	0.0131	CcSEcCtD
Phenobarbital—Hypothermia—Doxorubicin—muscle cancer	0.000629	0.0131	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.000614	0.0128	CcSEcCtD
Phenobarbital—CHRFAM7A—head—muscle cancer	0.000605	0.0172	CbGeAlD
Phenobarbital—GRIK2—head—muscle cancer	0.0006	0.017	CbGeAlD
Phenobarbital—SLCO2A1—head—muscle cancer	0.000596	0.0169	CbGeAlD
Phenobarbital—CHRFAM7A—testis—muscle cancer	0.000585	0.0166	CbGeAlD
Phenobarbital—SLCO2A1—testis—muscle cancer	0.000576	0.0163	CbGeAlD
Phenobarbital—Ataxia—Vincristine—muscle cancer	0.000572	0.0119	CcSEcCtD
Phenobarbital—CYP1B1—smooth muscle tissue—muscle cancer	0.000556	0.0158	CbGeAlD
Phenobarbital—ABCC2—renal system—muscle cancer	0.000547	0.0155	CbGeAlD
Phenobarbital—CYP1B1—renal system—muscle cancer	0.000535	0.0152	CbGeAlD
Phenobarbital—CYP2A6—vagina—muscle cancer	0.000529	0.015	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.000521	0.0109	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—muscle cancer	0.000518	0.0108	CcSEcCtD
Phenobarbital—Nystagmus—Doxorubicin—muscle cancer	0.000493	0.0103	CcSEcCtD
Phenobarbital—CHRNA7—head—muscle cancer	0.000489	0.0139	CbGeAlD
Phenobarbital—Blister—Doxorubicin—muscle cancer	0.000489	0.0102	CcSEcCtD
Phenobarbital—CHRNA4—head—muscle cancer	0.000482	0.0137	CbGeAlD
Phenobarbital—Apnoea—Methotrexate—muscle cancer	0.00048	0.01	CcSEcCtD
Phenobarbital—CHRNA7—testis—muscle cancer	0.000472	0.0134	CbGeAlD
Phenobarbital—Hepatitis—Dactinomycin—muscle cancer	0.000471	0.00983	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—muscle cancer	0.000466	0.00973	CcSEcCtD
Phenobarbital—ABCC3—head—muscle cancer	0.000458	0.013	CbGeAlD
Phenobarbital—Necrosis—Doxorubicin—muscle cancer	0.000449	0.00936	CcSEcCtD
Phenobarbital—Erythema multiforme—Dactinomycin—muscle cancer	0.000446	0.0093	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000444	0.00926	CcSEcCtD
Phenobarbital—ABCC3—testis—muscle cancer	0.000442	0.0125	CbGeAlD
Phenobarbital—ABCC1—cardiac atrium—muscle cancer	0.000431	0.0122	CbGeAlD
Phenobarbital—ABCC2—tendon—muscle cancer	0.000427	0.0121	CbGeAlD
Phenobarbital—Hallucination—Vincristine—muscle cancer	0.000419	0.00874	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—muscle cancer	0.000419	0.00874	CcSEcCtD
Phenobarbital—CYP1B1—tendon—muscle cancer	0.000418	0.0118	CbGeAlD
Phenobarbital—GABRA1—head—muscle cancer	0.000417	0.0118	CbGeAlD
Phenobarbital—Respiratory failure—Methotrexate—muscle cancer	0.000414	0.00864	CcSEcCtD
Phenobarbital—Erythema—Dactinomycin—muscle cancer	0.00041	0.00856	CcSEcCtD
Phenobarbital—CYP2C8—renal system—muscle cancer	0.00041	0.0116	CbGeAlD
Phenobarbital—Delirium—Doxorubicin—muscle cancer	0.00041	0.00855	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—muscle cancer	0.000404	0.00842	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—muscle cancer	0.000393	0.0082	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—muscle cancer	0.000385	0.00803	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—muscle cancer	0.000385	0.00803	CcSEcCtD
Phenobarbital—CYP1A2—renal system—muscle cancer	0.000384	0.0109	CbGeAlD
Phenobarbital—CYP1A1—renal system—muscle cancer	0.000378	0.0107	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000377	0.00786	CcSEcCtD
Phenobarbital—ABCC1—tendon—muscle cancer	0.000376	0.0107	CbGeAlD
Phenobarbital—Renal failure—Etoposide—muscle cancer	0.000374	0.00779	CcSEcCtD
Phenobarbital—Coma—Methotrexate—muscle cancer	0.000372	0.00776	CcSEcCtD
Phenobarbital—CYP3A5—renal system—muscle cancer	0.00037	0.0105	CbGeAlD
Phenobarbital—CYP2B6—renal system—muscle cancer	0.000368	0.0104	CbGeAlD
Phenobarbital—CYP1B1—head—muscle cancer	0.000358	0.0102	CbGeAlD
Phenobarbital—ABCC2—testis—muscle cancer	0.000353	0.01	CbGeAlD
Phenobarbital—Hepatocellular injury—Doxorubicin—muscle cancer	0.000352	0.00735	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—muscle cancer	0.00035	0.00731	CcSEcCtD
Phenobarbital—Myalgia—Dactinomycin—muscle cancer	0.000349	0.00729	CcSEcCtD
Phenobarbital—ABCC1—vagina—muscle cancer	0.000349	0.00989	CbGeAlD
Phenobarbital—CYP1B1—testis—muscle cancer	0.000346	0.00981	CbGeAlD
Phenobarbital—CYP2E1—renal system—muscle cancer	0.000345	0.00978	CbGeAlD
Phenobarbital—CYP2C19—vagina—muscle cancer	0.00034	0.00964	CbGeAlD
Phenobarbital—CYP1A1—cardiac atrium—muscle cancer	0.000339	0.00961	CbGeAlD
Phenobarbital—Agitation—Vincristine—muscle cancer	0.000337	0.00703	CcSEcCtD
Phenobarbital—Vertigo—Vincristine—muscle cancer	0.000329	0.00687	CcSEcCtD
Phenobarbital—Erythema multiforme—Etoposide—muscle cancer	0.000323	0.00673	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—muscle cancer	0.000322	0.00672	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000313	0.00653	CcSEcCtD
Phenobarbital—Myalgia—Vincristine—muscle cancer	0.000312	0.00651	CcSEcCtD
Phenobarbital—ABCC1—testis—muscle cancer	0.000311	0.00882	CbGeAlD
Phenobarbital—Mental disability—Doxorubicin—muscle cancer	0.000306	0.00638	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000305	0.00636	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—muscle cancer	0.000301	0.00629	CcSEcCtD
Phenobarbital—CYP2C8—vagina—muscle cancer	0.000297	0.00842	CbGeAlD
Phenobarbital—Pain—Dactinomycin—muscle cancer	0.000286	0.00597	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—muscle cancer	0.000282	0.00588	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—muscle cancer	0.00028	0.00584	CcSEcCtD
Phenobarbital—Hypotension—Vincristine—muscle cancer	0.00028	0.00583	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—muscle cancer	0.000278	0.00579	CcSEcCtD
Phenobarbital—CYP3A4—renal system—muscle cancer	0.000278	0.00787	CbGeAlD
Phenobarbital—Feeling abnormal—Dactinomycin—muscle cancer	0.000276	0.00576	CcSEcCtD
Phenobarbital—CYP1A1—vagina—muscle cancer	0.000274	0.00777	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000273	0.00569	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000271	0.00565	CcSEcCtD
Phenobarbital—CYP2E1—tendon—muscle cancer	0.000269	0.00764	CbGeAlD
Phenobarbital—CYP3A5—vagina—muscle cancer	0.000268	0.0076	CbGeAlD
Phenobarbital—Dermatitis bullous—Doxorubicin—muscle cancer	0.000268	0.00558	CcSEcCtD
Phenobarbital—Vertigo—Etoposide—muscle cancer	0.000267	0.00557	CcSEcCtD
Phenobarbital—CYP2B6—vagina—muscle cancer	0.000266	0.00755	CbGeAlD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000266	0.00555	CcSEcCtD
Phenobarbital—CYP2C8—testis—muscle cancer	0.000265	0.00751	CbGeAlD
Phenobarbital—Body temperature increased—Dactinomycin—muscle cancer	0.000265	0.00552	CcSEcCtD
Phenobarbital—Loss of consciousness—Etoposide—muscle cancer	0.000261	0.00545	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—muscle cancer	0.000261	0.00544	CcSEcCtD
Phenobarbital—ABCB1—embryo—muscle cancer	0.00026	0.00736	CbGeAlD
Phenobarbital—Constipation—Vincristine—muscle cancer	0.000256	0.00534	CcSEcCtD
Phenobarbital—Pain—Vincristine—muscle cancer	0.000256	0.00534	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—muscle cancer	0.000255	0.00533	CcSEcCtD
Phenobarbital—CYP1A1—head—muscle cancer	0.000253	0.00718	CbGeAlD
Phenobarbital—Affect lability—Doxorubicin—muscle cancer	0.000252	0.00525	CcSEcCtD
Phenobarbital—Hypersensitivity—Dactinomycin—muscle cancer	0.000247	0.00515	CcSEcCtD
Phenobarbital—CYP2B6—head—muscle cancer	0.000246	0.00698	CbGeAlD
Phenobarbital—Confusional state—Etoposide—muscle cancer	0.000244	0.0051	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—muscle cancer	0.000242	0.00505	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—muscle cancer	0.00024	0.00502	CcSEcCtD
Phenobarbital—CYP2B6—testis—muscle cancer	0.000238	0.00674	CbGeAlD
Phenobarbital—Body temperature increased—Vincristine—muscle cancer	0.000237	0.00493	CcSEcCtD
Phenobarbital—CYP2E1—head—muscle cancer	0.000231	0.00655	CbGeAlD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00023	0.0048	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—muscle cancer	0.000228	0.00475	CcSEcCtD
Phenobarbital—Hypotension—Etoposide—muscle cancer	0.000226	0.00472	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000226	0.00471	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—muscle cancer	0.000224	0.00467	CcSEcCtD
Phenobarbital—CYP2E1—testis—muscle cancer	0.000223	0.00632	CbGeAlD
Phenobarbital—Asthma—Doxorubicin—muscle cancer	0.000221	0.00461	CcSEcCtD
Phenobarbital—Hypersensitivity—Vincristine—muscle cancer	0.00022	0.0046	CcSEcCtD
Phenobarbital—Somnolence—Etoposide—muscle cancer	0.000215	0.00449	CcSEcCtD
Phenobarbital—Vomiting—Dactinomycin—muscle cancer	0.000213	0.00444	CcSEcCtD
Phenobarbital—Rash—Dactinomycin—muscle cancer	0.000211	0.0044	CcSEcCtD
Phenobarbital—Constipation—Etoposide—muscle cancer	0.000207	0.00432	CcSEcCtD
Phenobarbital—Pain—Etoposide—muscle cancer	0.000207	0.00432	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—muscle cancer	0.000204	0.00426	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—muscle cancer	0.0002	0.00417	CcSEcCtD
Phenobarbital—Nausea—Dactinomycin—muscle cancer	0.000199	0.00415	CcSEcCtD
Phenobarbital—Dizziness—Vincristine—muscle cancer	0.000198	0.00413	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—muscle cancer	0.000197	0.00411	CcSEcCtD
Phenobarbital—ABCB1—renal system—muscle cancer	0.000197	0.00557	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000195	0.00408	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—muscle cancer	0.000194	0.00404	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—muscle cancer	0.000193	0.00403	CcSEcCtD
Phenobarbital—Urticaria—Etoposide—muscle cancer	0.000193	0.00402	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—muscle cancer	0.000192	0.004	CcSEcCtD
Phenobarbital—Vomiting—Vincristine—muscle cancer	0.00019	0.00397	CcSEcCtD
Phenobarbital—Rash—Vincristine—muscle cancer	0.000189	0.00394	CcSEcCtD
Phenobarbital—Dermatitis—Vincristine—muscle cancer	0.000188	0.00393	CcSEcCtD
Phenobarbital—Headache—Vincristine—muscle cancer	0.000187	0.00391	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—muscle cancer	0.00018	0.00376	CcSEcCtD
Phenobarbital—Hypersensitivity—Etoposide—muscle cancer	0.000179	0.00373	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—muscle cancer	0.000178	0.00371	CcSEcCtD
Phenobarbital—Nausea—Vincristine—muscle cancer	0.000178	0.00371	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—muscle cancer	0.000177	0.00369	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—muscle cancer	0.000167	0.00349	CcSEcCtD
Phenobarbital—Dizziness—Etoposide—muscle cancer	0.00016	0.00334	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—muscle cancer	0.00016	0.00333	CcSEcCtD
Phenobarbital—Vomiting—Etoposide—muscle cancer	0.000154	0.00321	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—muscle cancer	0.000154	0.00321	CcSEcCtD
Phenobarbital—Rash—Etoposide—muscle cancer	0.000153	0.00319	CcSEcCtD
Phenobarbital—Dermatitis—Etoposide—muscle cancer	0.000153	0.00319	CcSEcCtD
Phenobarbital—Headache—Etoposide—muscle cancer	0.000152	0.00317	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—muscle cancer	0.000151	0.00316	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—muscle cancer	0.000151	0.00316	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—muscle cancer	0.000151	0.00315	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—muscle cancer	0.00015	0.00312	CcSEcCtD
Phenobarbital—ABCB1—bone marrow—muscle cancer	0.000149	0.00421	CbGeAlD
Phenobarbital—Confusional state—Methotrexate—muscle cancer	0.000146	0.00305	CcSEcCtD
Phenobarbital—Nausea—Etoposide—muscle cancer	0.000144	0.003	CcSEcCtD
Phenobarbital—ABCB1—vagina—muscle cancer	0.000142	0.00404	CbGeAlD
Phenobarbital—Agitation—Doxorubicin—muscle cancer	0.000142	0.00295	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—muscle cancer	0.000138	0.00289	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—muscle cancer	0.000138	0.00288	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—muscle cancer	0.000136	0.00283	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—muscle cancer	0.000135	0.00282	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000132	0.00276	CcSEcCtD
Phenobarbital—ABCB1—head—muscle cancer	0.000132	0.00373	CbGeAlD
Phenobarbital—Arthralgia—Doxorubicin—muscle cancer	0.000131	0.00274	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—muscle cancer	0.000131	0.00274	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—muscle cancer	0.000131	0.00273	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—muscle cancer	0.000129	0.00269	CcSEcCtD
Phenobarbital—ABCB1—testis—muscle cancer	0.000127	0.0036	CbGeAlD
Phenobarbital—Confusional state—Doxorubicin—muscle cancer	0.000127	0.00264	CcSEcCtD
Phenobarbital—Pain—Methotrexate—muscle cancer	0.000124	0.00259	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—muscle cancer	0.000124	0.00258	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—muscle cancer	0.00012	0.0025	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—muscle cancer	0.000117	0.00245	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—muscle cancer	0.000115	0.00241	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—muscle cancer	0.000115	0.00239	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000115	0.00239	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—muscle cancer	0.000112	0.00233	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—muscle cancer	0.000107	0.00224	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—muscle cancer	0.000107	0.00224	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—muscle cancer	0.000107	0.00223	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—muscle cancer	0.000104	0.00216	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—muscle cancer	9.99e-05	0.00208	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—muscle cancer	9.94e-05	0.00207	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—muscle cancer	9.6e-05	0.002	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—muscle cancer	9.26e-05	0.00193	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—muscle cancer	9.23e-05	0.00193	CcSEcCtD
Phenobarbital—Rash—Methotrexate—muscle cancer	9.15e-05	0.00191	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—muscle cancer	9.15e-05	0.00191	CcSEcCtD
Phenobarbital—Headache—Methotrexate—muscle cancer	9.09e-05	0.0019	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—muscle cancer	8.62e-05	0.0018	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—muscle cancer	8.31e-05	0.00173	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—muscle cancer	7.99e-05	0.00167	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—muscle cancer	7.93e-05	0.00165	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—muscle cancer	7.92e-05	0.00165	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—muscle cancer	7.88e-05	0.00164	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—muscle cancer	7.47e-05	0.00156	CcSEcCtD
